A stark divergence is emerging at telehealth provider Hims & Hers. The company is aggressively pursuing operational expansion, yet this stands in sharp c ...

Analysts are largely maintaining a "Hold" stance for now. The consensus average price target of $44.90 implies potential upside, but experts appear to be taking a wait-and-see approach. The key ...

Detailed price information for Soundhound Ai Inc Cl A (SOUN-Q) from The Globe and Mail including charting and trades.

Goldman Sachs Group Inc, SPDR® S&P 500® ETF Trust, MGM Resorts International, International Business Machines. Read 's Market Analysis on Investing.com ...

In a strategic pivot, the company has launched its weight-loss program in the United Kingdom. There, Hims & Hers is offering legitimate, branded medications—Novo Nordisk's Wegovy and Eli Lilly's ...

Hims reports that 70% of Americans believe an economic downturn encourages healthier habits, like cooking at home and ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Hims Hers Health Inc (NYSE:HIMS) stock fell 4.4% Wednesday after U.S. lawmakers introduced legislation that could ...

No financial data available at this time. Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its ...

Hims & Hers Health ($HIMS) stock recently earned a new Buy rating from Barclays at a price target of $48. Barclays sees ...

After a prolonged period of weakness, shares of the telehealth company Hims & Hers are showing tentative signs of a ...